Silver Book reference

Cost-Effectiveness of 2009 Pandemic Influenza A (H1N1) Vaccination in the United States

1 Matching Fact

Search matching Facts:
No results to display
    • Cost-effectiveness of flu vaccine
      Vaccination for pandemic influenza (pH1N1) prior to an outbreak produces incremental cost-effectiveness ratios for individuals without high risk conditions, ranging from $8,000 to $52,000 per quality-adjusted life year.